Trials / Unknown
UnknownNCT04548284
Study of Therapeutic Value of Periorbital Injection of Glucocorticoid in Mild TAO
Periorbitally Injected Glucocorticoids for Mild TAO: A Randomized Controlled Study
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 142 (estimated)
- Sponsor
- Sun Yat-sen University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether periorbital injection of glucocorticoid is effective and necessary in the treatment of mild TAO.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Glucocorticoids | Periorbital injection of glucocorticoid. Once every 3 weeks, the number of injections was determined according to the condition of the eyes during the follow-up. |
Timeline
- Start date
- 2021-05-01
- Primary completion
- 2023-06-01
- Completion
- 2023-12-01
- First posted
- 2020-09-14
- Last updated
- 2021-05-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04548284. Inclusion in this directory is not an endorsement.